- Home
- »
- Products & Services
- »
- Antibacterial Drugs
Antibacterial Drugs
Cefixime 200 Mg Lactic Acid Bacillus Tablet
Product Brochure
| Cefixime Strength | 200 mg |
| Lactic Acid Bacillus | 60 million |
| Pack Size | 10 tablets |
| Dosage Form | Dispersible |
| Packaging Type | Alu alu |
| Brand | Xoxim-LB |
| Usage | Respiratory |
| Prescription | Prescription |
Tab Xoxim-200LB
Cefixime 200 mg + Lactobacillus 60 Billion Spores – Brief Product Introduction
Cefixime 200 mg + Lactobacillus 60 Billion CFU Tablets are a combination therapy designed to provide effective antibacterial treatment while protecting gut health. This formulation helps manage bacterial infections and reduces the risk of antibiotic-associated digestive disturbances such as diarrhea, bloating, and stomach discomfort.
Mode of Action
Cefixime works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria and effective infection control.
Lactobacillus helps restore and maintain healthy intestinal microflora, preventing disruption caused by antibiotic therapy and reducing gastrointestinal side effects.
Together, they ensure strong infection control with improved digestive tolerance.
Key Benefits
- Broad-spectrum antibacterial coverage
- Effective in respiratory tract infections, ENT infections, urinary tract infections, gastrointestinal infections, and skin infections
- Helps prevent antibiotic-associated diarrhea and digestive discomfort
- Supports healthy gut flora balance and better patient compliance
- Faster recovery with improved gastrointestinal tolerance
- Suitable for patients requiring prolonged antibiotic therapy
Common Side Effects
- Nausea
- Vomiting
- Diarrhea or loose stools
- Abdominal discomfort
- Mild skin rash
- Loss of appetite
- Bloating or gastric irritation
Contraindications
- Known hypersensitivity to Cefixime, cephalosporins, penicillins, or probiotic components
- History of severe allergic reactions to beta-lactam antibiotics
- Severe kidney impairment (requires dose adjustment and supervision)
- Gastrointestinal disorders requiring medical caution
- Use during pregnancy and lactation only under physician guidance
This combination should be used under medical supervision to ensure safe and effective bacterial infection treatment while maintaining digestive comfort and reducing the risk of antibiotic resistance.
Cefixime And Potassium Clavulanate Tablet
Product Brochure
| Strength | 325 mg |
| Packaging Size | 10×10 tablets |
| Brand | Xoxim-CV |
| Formulation Type | Film coated |
| Packaging Type | Alu alu |
| Prescription Type | Prescription |
| Usage | Clinic |
| Shelf Life | 24 months |
| Dosage Form | Tablet |
| Country of Origin | India |
Tab Xoxim-CV
Cefixime 200 mg + Clavulanate 125 mg Tablets – Brief Product Introduction
Cefixime 200 mg + Clavulanic acid 125 mg Tablets are a powerful broad-spectrum antibiotic combination used for the treatment of various bacterial infections, especially those caused by resistant organisms. This combination provides enhanced antibacterial action and improved protection against beta-lactamase producing bacteria, making it effective in respiratory, urinary, ENT, skin, and soft tissue infections.
Mode of ActionCefixime works by inhibiting bacterial cell wall synthesis, leading to bacterial destruction.
Clavulanic acid acts as a beta-lactamase inhibitor, protecting Cefixime from bacterial resistance caused by beta-lactamase enzymes and enhancing its antibacterial effectiveness.
Together, they provide stronger infection control and broader bacterial coverage.
Key Benefits- Broad-spectrum antibacterial coverage
- Effective against resistant bacterial infections
- Useful in respiratory tract infections, ENT infections, urinary tract infections, skin infections, and soft tissue infections
- Helps reduce recurrence and improves faster clinical recovery
- Strong protection against beta-lactamase producing bacteria
- Convenient oral therapy with reliable therapeutic response
- Nausea
- Vomiting
- Diarrhea
- Abdominal discomfort
- Mild skin rash
- Loss of appetite
- Gastric discomfort
- Known hypersensitivity to Cefixime, Clavulanate, cephalosporins, penicillins, or related antibiotics
- History of severe allergic reactions to beta-lactam antibiotics
- Severe kidney or liver impairment (requires medical supervision)
- Gastrointestinal disorders requiring caution
- Use during pregnancy and lactation only under physician guidance
This combination should be used under medical supervision to ensure safe and effective bacterial infection management while helping prevent antibiotic resistance.
Cefixime Ofloxacin Tablet
Product Brochure
| Cefixime Strength | 200 mg |
| Ofloxacin Strength | 200 mg |
| Packaging Size | 10x10 Tablets |
| Packaging Type | Alu-Alu |
| Form | Tablet |
| Therapeutic Add-on | Lactic Acid Bacillus |
| Other | Xoxim-OF |
Tab Xoxim-OF
Cefixime 200 mg + Ofloxacin 200 mg Tablets – Brief Product Introduction
Cefixime 200 mg + Ofloxacin 200 mg Tablets are a broad-spectrum antibiotic combination used for the treatment of various bacterial infections. This dual-action therapy provides enhanced coverage against both Gram-positive and Gram-negative bacteria, making it effective in respiratory, urinary, gastrointestinal, ENT, and skin infections.
Mode of Action
Cefixime works by inhibiting bacterial cell wall synthesis, leading to bacterial destruction.
Ofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, preventing bacterial replication and growth.
Together, they offer stronger and broader antibacterial action for faster recovery.
Key Benefits
- Broad-spectrum antibacterial coverage
- Effective against Gram-positive and Gram-negative bacterial infections
- Useful in respiratory tract infections, ENT infections, urinary tract infections, gastrointestinal infections, and skin infections
- Helps manage recurrent and mixed bacterial infections
- Faster symptom relief and improved clinical recovery
- Convenient oral therapy with strong therapeutic response
Common Side Effects
- Nausea
- Vomiting
- Diarrhea
- Abdominal discomfort
- Headache
- Dizziness
- Mild skin rash
Contraindications
- Known hypersensitivity to Cefixime, Ofloxacin, cephalosporins, quinolones, or related antibiotics
- Patients with seizure disorders (use with caution)
- Severe kidney or liver impairment
- History of tendon disorders related to quinolone use
- Pregnancy and pediatric use only under medical supervision
This combination should be used under medical supervision to ensure safe and effective treatment and to help reduce the development of antibiotic resistance.
Ceftazidime 1 Gm Tazobactam 125 Mg Injection
Product Brochure
| Ceftazidime strength | 1 g |
| Tazobactam strength | 125 mg |
| Pack size | 1 vial |
| Usage | IV use |
| Form | Dry powder |
| Brand type | Branded |
| Prescription | Prescription |
| Storage | Below 25 C |
| Shelf life | 24 months |
| Company type | Pcd company |
Ceftazidime 1 gm + Tazobactam 125 mg Injection – Brief Product Introduction
Ceftazidime 1 gm + Tazobactam 125 mg Injection is a powerful broad-spectrum antibiotic combination used for the treatment of moderate to severe bacterial infections, especially those caused by resistant Gram-negative organisms and beta-lactamase producing bacteria. It is commonly prescribed in hospitals for respiratory tract infections, urinary tract infections, septicemia, intra-abdominal infections, skin and soft tissue infections, and post-surgical infections.
Mode of ActionCeftazidime works by inhibiting bacterial cell wall synthesis, leading to bacterial destruction.
Tazobactam acts as a beta-lactamase inhibitor, protecting Ceftazidime from bacterial enzyme-mediated resistance and enhancing its antibacterial effectiveness.
Together, they provide stronger infection control and broader antibacterial coverage.
Key Benefits- Broad-spectrum antibacterial coverage
- Effective against resistant Gram-negative and beta-lactamase producing bacterial infections
- Useful in pneumonia, UTIs, septicemia, intra-abdominal infections, skin infections, and hospital-acquired infections
- Strong bactericidal action with rapid clinical response
- Reliable injectable therapy for critical care and severe infections
- Helps manage complicated and resistant infections effectively
- Injection site pain
- Nausea
- Vomiting
- Diarrhea
- Mild skin rash
- Headache
- Temporary liver enzyme elevation
- Known hypersensitivity to Ceftazidime, Tazobactam, cephalosporins, penicillins, or related beta-lactam antibiotics
- History of severe allergic reactions to beta-lactam antibiotics
- Severe kidney impairment (dose adjustment may be required)
- Gastrointestinal disorders requiring caution
- Use during pregnancy and lactation only under physician guidance
This combination should be used under strict medical supervision to ensure safe and effective infection management while helping prevent bacterial resistance and treatment failure.
Meropenem 1gm Injection
Product Brochure
| Strength | 1 g |
| Brand | Meronu 1g |
| Form | Vial |
| Composition | Meropenem |
| Route of Administration | IV |
| Packaging Size | 1 vial + WFI |
| Injection Type | Powder for injection |
| Pharmacopoeia Standard | IP |
| Usage | Human |
Inj Meronu 1g
Meropenem 1 g Injection – Brief Product Introduction
Meropenem 1 g Injection is a powerful broad-spectrum carbapenem antibiotic used for the treatment of severe and complicated bacterial infections caused by susceptible organisms. It is highly effective against a wide range of Gram-positive, Gram-negative, and anaerobic bacteria, making it suitable for hospital and critical care use in serious infections such as septicemia, pneumonia, intra-abdominal infections, meningitis, urinary tract infections, and post-surgical infections.
Mode of ActionMeropenem works by inhibiting bacterial cell wall synthesis, leading to rapid bacterial destruction. Its strong bactericidal action helps control severe infections quickly and effectively.
Key Benefits- Broad-spectrum antibacterial coverage
- Effective against severe Gram-positive, Gram-negative, and anaerobic bacterial infections
- Useful in pneumonia, septicemia, meningitis, UTIs, intra-abdominal infections, and hospital-acquired infections
- Rapid bactericidal action with strong clinical response
- Reliable injectable therapy for emergency and critical care management
- Effective against many resistant bacterial strains
- Nausea
- Vomiting
- Diarrhea
- Injection site pain
- Headache
- Skin rash
- Temporary liver enzyme elevation
- Known hypersensitivity to Meropenem, carbapenems, or other beta-lactam antibiotics
- History of severe allergic reactions to penicillins or cephalosporins
- Patients with seizure disorders or CNS disorders (use with caution)
- Severe kidney impairment (dose adjustment required)
- Use during pregnancy and lactation only under strict medical supervision
Meropenem Injection should be used under hospital supervision to ensure safe and effective treatment of serious infections while minimizing the risk of resistance and adverse effects.